Blog

12 March 2025 - PHARMAC is funding six more medicines for cancers and one for antibiotic resistant infections. ...

10 March 2025 - PHARMAC is seeking public feedback on a proposal to fund a new, additional type of insulin ...

28 February 2025 - The Board of PHARMAC wishes to announce that its Chief Executive for the last 7 years, ...

1 March 2025 - The March 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

12 February 2025 - People with liver, ovarian, and neuroendocrine cancers will have access to more medicines from 1 March ...

3 February 2025 - PHARMAC is consulting on funding a new progestogen-only oral contraceptive pill called desogestrel (Cerazette) from 1 ...

1 February 2025 - The February 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

29 January 2025 - PHARMAC is reviewing and reconsidering its oestradiol patch options after considerable feedback was received when it ...

16 January 2025 - PHARMAC is asking for feedback on a proposal to widen access to three medicines for five ...

10 January 2025 - PHARMAC is widening access to a medicine called denosumab for people with osteoporosis.  ...

1 January 2025 - The January 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

23 December 2024 - PHARMAC has published information on what the PTAC will be considering at its upcoming meeting in ...

19 December 2024 - PHARMAC is asking for feedback on proposals to fund six medicines for cancer and antibiotic resistant ...

9 December 2024 - PHARMAC is consulting on a proposal to fund bevacizumab (branded as Vegzelma) as a cancer medicine ...